Dengue is caused by a taxonomic group of four viruses, dengue virus types 1–4 (DENV1–DENV4). A molecular understanding of the antibody-mediated protection against this disease is critical to design safe vaccines and therapeutics. Here, the energetic epitope of antibody mAb4E11, which neutralizes the four serotypes of DENV but no other flavivirus, and binds domain 3 (ED3) of their envelope glycoprotein, was characterized. Alanine-scanning mutagenesis of the ED3 domain from serotype DENV1 was performed and the affinities between the mutant domains and the Fab fragment of mAb4E11 were measured. The epitope residues (307–312, 387, 389 and 391) were at the edges of two distinct β-sheets. Four residues constituted hot spots of binding energy. They were aliphatic and contributed to form a hydrophobic pocket (Leu308, Leu389), or were positively charged (Lys307, Lys310). They may bind the diversity residues of mAb4E11, H-Trp96-Glu97. Remarkably, cyclic residues occupy and block the hydrophobic pocket in all unrelated flaviviruses. Transplanting the epitope from the ED3 domain of DENV into those of other flaviviruses restored affinity. The epitope straddles residues of ED3 that are involved in virulence, e.g. Asn/Asp390. These results define the epitope of mAb4E11 as an antigenic signature of the DENV group and suggest mechanisms for its neutralization potency.
BeasleyD. W.,
BarrettA. D.2002; Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein. J Virol 76:13097–13100[CrossRef]
BedouelleH.,
BelkadiL.,
EnglandP.,
GuijarroJ. I.,
LisovaO.,
UrvoasA.,
DelepierreM.,
ThullierP.2006; Diversity and junction residues as hotspots of binding energy in an antibody neutralizing the dengue virus. FEBS J 273:34–46[CrossRef]
BhardwajS.,
HolbrookM.,
ShopeR. E.,
BarrettA. D.,
WatowichS. J.2001; Biophysical characterization and vector-specific antagonist activity of domain III of the tick-borne flavivirus envelope protein. J Virol 75:4002–4007[CrossRef]
CatteauA.,
KalininaO.,
WagnerM. C.,
DeubelV.,
CourageotM. P.,
DespresP.2003; Dengue virus M protein contains a proapoptotic sequence referred to as ApoptoM. J Gen Virol 84:2781–2793[CrossRef]
CeciliaD.,
GouldE. A.1991; Nucleotide changes responsible for loss of neuroinvasiveness in Japanese encephalitis virus neutralization-resistant mutants. Virology 181:70–77[CrossRef]
ChambersT. J.,
HalevyM.,
NestorowiczA.,
RiceC. M.,
LustigS.1998; West Nile virus envelope proteins: nucleotide sequence analysis of strains differing in mouse neuroinvasiveness. J Gen Virol 79:2375–2380
ChenY.,
MaguireT.,
HilemanR. E.,
FrommJ. R.,
EskoJ. D.,
LinhardtR. J.,
MarksR. M.1997; Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat Med 3:866–871[CrossRef]
CreightonT. E.1989; Disulphide bonds between cysteine residues. In Protein Structure: a Practical Approach pp 155–168 Edited by
CreightonT. E.
Oxford: IRL Press;
CrillW. D.,
RoehrigJ. T.2001; Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J Virol 75:7769–7773[CrossRef]
FriguetB.,
ChaffotteA. F.,
Djavadi-OhanianceL.,
GoldbergM. E.1985; Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay. J Immunol Methods 77:305–319[CrossRef]
GoncalvezA. P.,
PurcellR. H.,
LaiC. J.2004; Epitope determinants of a chimpanzee Fab antibody that efficiently cross-neutralizes dengue type 1 and type 2 viruses map to inside and in close proximity to fusion loop of the dengue type 2 virus envelope glycoprotein. J Virol 78:12919–12928[CrossRef]
GublerD. J.2002; Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol 10:100–103[CrossRef]
HeinzF. X.,
CollettM. S.,
PurcellR. H.,
GouldE. A.,
HowardC. R.,
HoughtonM.,
MoormannR. J. M.,
RiceC. M.,
ThielH. J.2000; Family Flaviviridae
. In Virus Taxonomy: Seventh Report of the International Committee on Taxonomy of Viruses pp 859–878 Edited by
van RegenmortelM. V. E.,
FauquetC. M.,
BishopD. H. L.,
CarstensE. B.,
EstesM. K.,
LemonS. M.,
ManiloffJ.,
MayoM. A.,
McGeochD. J.,
PringleC. R.,
WicknerR. B.
San Diego, CA: Academic Press;
HolzmannH.,
HeinzF. X.,
MandlC. W.,
GuirakhooF.,
KunzC.1990; A single amino acid substitution in envelope protein E of tick-borne encephalitis virus leads to attenuation in the mouse model. J Virol 64:5156–5159
HungJ. J.,
HsiehM. T.,
YoungM. J.,
KaoC. L.,
KingC. C.,
ChangW.2004; An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells. J Virol 78:378–388[CrossRef]
JenningsA. D.,
GibsonC. A.,
MillerB. R.,
MathewsJ. H.,
MitchellC. J.,
RoehrigJ. T.,
WoodD. J.,
TaffsF.,
SilB. K.other authors1994; Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis. J Infect Dis 169:512–518[CrossRef]
JiangW.,
BonnertT. P.,
VenugopalK.,
GouldE. A.1994; A single chain antibody fragment expressed in bacteria neutralizes tick-borne flaviviruses. Virology 200:21–28[CrossRef]
LeitmeyerK. C.,
VaughnD. W.,
WattsD. M.,
SalasR.,
VillalobosI.,
de Chacon RamosC.,
Rico-HesseR.1999; Dengue virus structural differences that correlate with pathogenesis. J Virol 73:4738–4747
LiL.,
BarrettA. D.,
BeasleyD. W.2005; Differential expression of domain III neutralizing epitopes on the envelope proteins of West Nile virus strains. Virology 335:99–105[CrossRef]
LinC. W.,
WuS. C.2003; A functional epitope determinant on domain III of the Japanese encephalitis virus envelope protein interacted with neutralizing-antibody combining sites. J Virol 77:2600–2606[CrossRef]
LinB.,
ParrishC. R.,
MurrayJ. M.,
WrightP. J.1994; Localization of a neutralizing epitope on the envelope protein of dengue virus type 2. Virology 202:885–890[CrossRef]
LokS. M.,
NgM. L.,
AaskovJ.2001; Amino acid and phenotypic changes in dengue 2 virus associated with escape from neutralisation by IgM antibody. J Med Virol 65:315–323[CrossRef]
MandlC. W.,
GuirakhooF.,
HolzmannH.,
HeinzF. X.,
KunzC.1989; Antigenic structure of the flavivirus envelope protein E at the molecular level, using tick-borne encephalitis virus as a model. J Virol 63:564–571
MegretF.,
HugnotJ. P.,
FalconarA.,
GentryM. K.,
MorensD. M.,
MurrayJ. M.,
SchlesingerJ. J.,
WrightP. J.,
YoungP.other authors1992; Use of recombinant fusion proteins and monoclonal antibodies to define linear and discontinuous antigenic sites on the dengue virus envelope glycoprotein. Virology 187:480–491[CrossRef]
ModisY.,
OgataS.,
ClementsD.,
HarrisonS. C.2003; A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci U S A 100:6986–6991[CrossRef]
MongkolsapayaJ.,
DejnirattisaiW.,
XuX. N.,
VasanawathanaS.,
TangthawornchaikulN.,
ChairunsriA.,
SawasdivornS.,
DuangchindaT.,
DongT.other authors2003; Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med 9:921–927[CrossRef]
MonsellierE.,
BedouelleH.2005; Quantitative measurement of protein stability from unfolding equilibria monitored with the fluorescence maximum wavelength. Protein Eng Des Sel 18:445–456[CrossRef]
Navarro-SanchezE.,
AltmeyerR.,
AmaraA.,
SchwartzO.,
FieschiF.,
VirelizierJ. L.,
Arenzana-SeisdedosF.,
DespresP.2003; Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses. EMBO Rep 4:723–728[CrossRef]
NybakkenG. E.,
OliphantT.,
JohnsonS.,
BurkeS.,
DiamondM. S.,
FremontD. H.2005; Structural basis of West Nile virus neutralization by a therapeutic antibody. Nature 437:764–769[CrossRef]
OliphantT.,
EngleM.,
NybakkenG. E.,
DoaneC.,
JohnsonS.,
HuangL.,
GorlatovS.,
MehlhopE.,
MarriA.other authors2005; Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat Med 11:522–530[CrossRef]
PaceC. N.,
VajdosF.,
FeeL.,
GrimsleyG.,
GrayT.1995; How to measure and predict the molar absorption coefficient of a protein. Protein Sci 4:2411–2423[CrossRef]
PokidyshevaE.,
ZhangY.,
BattistiA. J.,
Bator-KellyC. M.,
ChipmanP. R.,
XiaoC.,
GregorioG. G.,
HendricksonW. A.,
KuhnR. J.,
RossmannM. G.2006; Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN. Cell 124:485–493[CrossRef]
PryorM. J.,
CarrJ. M.,
HockingH.,
DavidsonA. D.,
LiP.,
WrightP. J.2001; Replication of dengue virus type 2 in human monocyte-derived macrophages: comparisons of isolates and recombinant viruses with substitutions at amino acid 390 in the envelope glycoprotein. Am J Trop Med Hyg 65:427–434
RenardM.,
BelkadiL.,
BedouelleH.2003; Deriving topological constraints from functional data for the design of reagentless fluorescent immunosensors. J Mol Biol 326:167–175[CrossRef]
RoehrigJ. T.,
BolinR. A.,
KellyR. G.1998; Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica. Virology 246:317–328[CrossRef]
RoehrigJ. T.,
VolpeK. E.,
SquiresJ.,
HuntA. R.,
DavisB. S.,
ChangG. J.2004; Contribution of disulfide bridging to epitope expression of the dengue type 2 virus envelope glycoprotein. J Virol 78:2648–2652[CrossRef]
RondardP.,
BedouelleH.1998; A mutational approach shows similar mechanisms of recognition for the isolated and integrated versions of a protein epitope. J Biol Chem 273:34753–34759[CrossRef]
RondardP.,
GoldbergM. E.,
BedouelleH.1997; Mutational analysis of an antigenic peptide shows recognition in a loop conformation. Biochemistry 36:8962–8968[CrossRef]
RymanK. D.,
LedgerT. N.,
CampbellG. A.,
WatowichS. J.,
BarrettA. D.1998; Mutation in a 17D–204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice. Virology 244:59–65[CrossRef]
SanchezI. J.,
RuizB. H.1996; A single nucleotide change in the E protein gene of dengue virus 2 Mexican strain affects neurovirulence in mice. J Gen Virol 77:2541–2545[CrossRef]
SchlesingerJ. J.,
ChapmanS.,
NestorowiczA.,
RiceC. M.,
GinocchioT. E.,
ChambersT. J.1996; Replication of yellow fever virus in the mouse central nervous system: comparison of neuroadapted and non-neuroadapted virus and partial sequence analysis of the neuroadapted strain. J Gen Virol 77:1277–1285[CrossRef]
SeifS. A.,
MoritaK.,
IgarashiA.1996; A 27 amino acid coding region of JE virus E protein expressed in E. coli as fusion protein with glutathione-S-transferase elicit neutralizing antibody in mice. Virus Res 43:91–96[CrossRef]
SerafinI. L.,
AaskovJ. G.2001; Identification of epitopes on the envelope (E) protein of dengue 2 and dengue 3 viruses using monoclonal antibodies. Arch Virol 146:2469–2479[CrossRef]
ThepparitC.,
SmithD. R.2004; Serotype-specific entry of dengue virus into liver cells: identification of the 37-kilodalton/67-kilodalton high-affinity laminin receptor as a dengue virus serotype 1 receptor. J Virol 78:12647–12656[CrossRef]
ThullierP.,
DemangelC.,
BedouelleH.,
MegretF.,
JouanA.,
DeubelV.,
MazieJ. C.,
LafayeP.2001; Mapping of a dengue virus neutralizing epitope critical for the infectivity of all serotypes: insight into the neutralization mechanism. J Gen Virol 82:1885–1892
UrbanA.,
NeukirchenS.,
JaegerK. E.1997; A rapid and efficient method for site-directed mutagenesis using one-step overlap extension PCR. Nucleic Acids Res 25:2227–2228[CrossRef]
VolkD. E.,
BeasleyD. W.,
KallickD. A.,
HolbrookM. R.,
BarrettA. D.,
GorensteinD. G.2004; Solution structure and antibody binding studies of the envelope protein domain III from the New York strain of West Nile virus. J Biol Chem 279:38755–38761[CrossRef]
VolkD. E.,
LeeY. C.,
LiX.,
ThiviyanathanV.,
GromowskiG. D.,
LiL.,
LambA. R.,
BeasleyD. W.,
BarrettA. D.,
GorensteinD. G.2007; Solution structure of the envelope protein domain III of dengue-4 virus. Virology 364:147–154[CrossRef]
WuS. C.,
LinC. W.2001; Neutralizing peptide ligands selected from phage-displayed libraries mimic the conformational epitope on domain III of the Japanese encephalitis virus envelope protein. Virus Res 76:59–69[CrossRef]
WuS. C.,
LianW. C.,
HsuL. C.,
LiauM. Y.1997; Japanese encephalitis virus antigenic variants with characteristic differences in neutralization resistance and mouse virulence. Virus Res 51:173–181[CrossRef]
WuK. P.,
WuC. W.,
TsaoY. P.,
KuoT. W.,
LouY. C.,
LinC. W.,
WuS. C.,
ChengJ. W.2003; Structural basis of a flavivirus recognized by its neutralizing antibody: solution structure of the domain III of the Japanese encephalitis virus envelope protein. J Biol Chem 278:46007–46013[CrossRef]